Alumnus studies disease treatments

A science entrepreneur who grew up in Summerland is working on treatments for Parkinson’s Disease and Huntington’s Disease.

A science entrepreneur who grew up in Summerland is working on treatments for Parkinson’s Disease and Huntington’s Disease.

Joost Schulte graduated from Summerland Secondary School in 1988 and has since completed a Bachelor of Science in biochemistry and cell biology and a Ph.D. in genetics and neuroscience from the University of British Columbia.

He was a staff scientist at EnVivo Pharmaceuticals in Watertown, Massachusetts for two years, where he was the lead inventor on one of the company’s first patents.

He and Katharine Sepp co-founded Oxalys Pharmaceuticals, based on discoveries they made at Massachusetts Institute of Technology.

Their work today is on treatments for neurodegenerative disorders such as Huntington’s disease and Parkinson’s disease.

Their experimental therapeutic for Huntington’s disease was discovered because of its capacity to stimulate brain cell growth, and survival. In treating Huntington’s disease, this drug could potentially delay disease onset as well as treating symptoms.

“This works in animal models,” he said. “Now we have to show it functions the same way in patients.”

He added that the drug is not a cure for the disease. “The patients will still carry the Huntington’s mutation.”

A Parkinson’s disease treatment in development may also delay disease onset, although more research is still needed.

This drug eliminates toxic proteins that cause the disease. “Preliminary studies are incredibly exciting as they show great promise,” he said.

Since Oxalys Pharmaceuticals works with repurposing existing drugs, the development is much faster than if the drugs are developed from the beginning.

Immediate next steps for Oxalys are to complete a Phase I clinical trial for their Huntington’s therapeutic.

Schulte said it will be the first drug they are bringing to the market and in a best-case scenario it could be on the market in five years although timelines are difficult to predict with certainty.

In addition to the pharmaceutical research, Schulte said part of his work is in raising the necessary funds for the work.

The company has used government research and development grants and private investment money to conduct their product development.

Recently, Oxalys won grants from the Michael J. Fox Foundation and the National Research Council of Canada, as well as an award from the Ontario Brain Institute.

 

 

Just Posted

LETTER: Thanks to all who ran in election

To those that were elected, I look forward to your collective stewardship

Kettle Valley Steam Railway holds train ride of terror

Summerland tourist train will have Halloween-themed events

Ballet Kelowna to kick off 16th season with pair of premiers

Fresh off performances in Beijing and Toronto, company will perform at KCT Nov. 16 and 17

LETTER: Support candidates who will assist cannabis industry

Cannabis has often provided extra income for fruit growers or paid the bills for students

COLUMN: Life is So Good: A biography to remember

George Dawson was African American at a time of great racial discrimination

B.C. sailor surprised by humpback whale playing under her boat

Jodi Klahm-Kozicki said the experience was ‘magical’ near Denman Island

VOTE: Nature in Focus reader’s choice photo contest

The Penticton Western News Reader’s Choice photo contest

Who is running in Summerland’s election?

Introducing you to the candidates asking for your vote on Oct. 20

Ovechkin has 4 points as Caps rough up Canucks 5-2

WATCH: Defending champs pick up impressive win in Vancouver

World Junior Hockey fever hits Vernon

Vipers spice up floor ball demonstration at OK Landing School

Shuswap refugee family settles into new, more hopeful life

Father of 10th Syrian family to come to Salmon Arm says learning English, work, top priorities

RCMP seek missing Vernon man

Michael Ramsey, 49, was last seen Oct. 21

B.C. government moves to tighten resource industry regulations

New superintendent will oversee engineers, biologists, foresters

Most Read